Medical
Oxygen Concentrators Market Overview by Product, Technology, Indication, End
User and Region - Forecast till 2030.The medical oxygen concentrators
market size is expected to reach USD 4.8 billion by 2030 at 5% CAGR during the
forecast period 2022-2030.Demand for oxygen therapies had been rising in the
last couple of decades as numerous studies have pointed out that patients who undergo
oxygen therapy live longer and lead more active lives. Medical oxygen
concentrators market has therefore been expanding as oxygen concentrators have
come to be increasingly used in not only hospitals and clinics but at homes by
patients who require outpatient treatments or patients who wish to travel and
continue to lead normal lives with considerable mobility in spite of the need
for continuous requirement of oxygen supply.
Oxygen
concentrators are less portable than the other options. An oxygen concentrator
is a device that takes oxygen from the room, concentrates it for therapeutic
use, and removes other naturally occurring gases. The benefits of concentrators
are that they are less expensive and don’t require filling like tanks. Portable
versions are available. However, most models are too large to be truly
portable.
Competitive Landscape:
Some of the
companies that are making considerable contribution to the medical oxygen
concentrators market include Philips Healthcare, Invacare Corporation, AirSep
Corporation, Drive DeVilbiss Healthcare, Medtronic plc, ResMed, Chart
Industries, Inc., Nidek Medical Products, Inc., Precision Medical, Inc., GCE
Group, Besco Medical Limited, O2 Concepts, LLC, Inogen, Teijin Limited, OSI -
Oxygen Solutions Inc.
Segmentation
The global medical oxygen concentrators
market has been segmented into product, technology, indication, end user, and
region.
By product, the market has been segmented
into portable oxygen concentrators and stationary oxygen concentrators.
On the basis of technology, the market has
been divided into the continuous flow and pulse dose.
Based on indication, the market has been
categorized into chronic obstructive pulmonary disease, asthma, sleep apnea,
and others.
By end user, the market has been classified
into homecare, travel, hospitals and clinics, and others. Home oxygen
concentrators facilitate convenience and make it easier and safer for the
patient to complete their day-to-day activities, which is supporting the
dominance of the homecare segment during the next six years.
Regional Analysis:
Geographically,
the North America held a substantial share in the medical
oxygen concentrators market research report in 2018 which can be attributed
to the presence of established home healthcare care services, active
participation of key market players, increasing incidence of respiratory
diseases, and favorable reimbursement scenario in the U.S. and Canada.
Expanding
geriatric population in Europe coupled with rising prevalence of asthma,
pulmonary hypertension, COPD, and fibrosis, would lead the region to be
the second largest value contributor to the medical oxygen concentrators
market.
Increasing
healthcare expenditure, improvement in healthcare infrastructure and expanding
awareness about need for oxygen concentrators will augment Asia-Pacific medical
oxygen concentrators market growth. The region is anticipated to register the
fastest market CAGR over 2018-2024 owing to increasing demand for portable
concentrators.
The medical
oxygen concentrators market in the Middle East & Africa would witness the
modest market growth rate from 2018 to 2024. The Middle East would spearhead
the market attributed to the rising prevalence of sleep apnea.
About US:
Market Research
Future (MRFR), enable customers to unravel the complexity of various industries
through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services.
The Wall